13:42 PM
Alberto-Culver (ACV) gets a boost from Caris after analysts upgrade shares to Buy with $30 target. Firm says it expects ACV to deliver at least 11% EPS growth in 2009 despite a rough economy - driven by 7% organic sales growth. ACV +7.6% to $23.
Comment!
Monday, October 27, 2008
07:38 AMAlberto-Culver (ACV): FQ4 EPS of $0.31 in-line. Revenue of $386M (+7.3%) vs. $375M. (PR)
Comment!
Wednesday, August 20, 2008
15:50 PM
High-end beauty products are outperforming - confounding assumptions prestige products would be among the first to fall. Plays include Bare Escentuals (BARE), Estee Lauder (EL), and Alberto-Culver's (ACV) Nexxus.
Comment!